Production & Manufacturing
Fine & Speciality Chemicals

Fine & Speciality Chemicals White Papers

View white papers from other Pharmaceutical sectors:
31-45 of 51 results
Assessment of the Impact of the European Pharmacopoeia Monograph for Norflurane
| By Mexichem Fluor
A draft monograph for HFA 134a (norflurane) was first published in the April 2011 edition of PHARMAEUROPA (Volume 23, No.2), with the usual period for comment and review. Mexichem Fluor provided comments on this draft via the appropriate national pharmacopoeia authority, in this case the British Pharmacopoeia. The final monograph was included in Supplement 7.7 (published 1 October 2012) to the 7th Edition of European Pharmacopoeia (Ph Eur). Supplement 7.7 has an implementation date of 1 April 2013.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
A short history of cell culture media and the use of insulin
| By Novo Nordisk Pharmatech A/S
The ancestors of cell culture media were the balanced salt solutions (BSS) devised by early workers interested in studying isolated organs ex vivo. The first BSS was composed in 1885 by Sydney Ringer (1836-1910), a British clinician and pharmacologist from University College London who worked on the isolated frog heart.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Introduction of Pierre de Meyts. MD, PhD, F.A.C.E
| By Novo Nordisk Pharmatech A/S
Pierre de Meyts is an expert who has worked with and researched insulin and receptor binding for almost half a century. FeF Chemicals A/S is proud to present what we assume to be one of the best pieces describing the functionality of insulin and insulin like growth factors, with respect to receptor binding and cellular response.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
SOLUTIONS IN QUATS THAT FIT YOUR REQUIREMENTS cGMP Pharmaceutical Grade APIs & Excipients
| By Novo Nordisk Pharmatech A/S
FeF Chemicals is the worldwide leading supplier of high quality Quaternary Ammonium Compounds (quats). We are specialized in the pharmaceutical and personal care industries, providing quats of global regulatory compliance. We provide only the very best and safest ingredients for your formulation, preserving its quality and contributing to patient safety.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
An Assessment of the Suitability of the Xcelodose 600 System in the Filling of Blended Products
| By Capsugel
In wall poster format, this study captures how Capsugel's Xcelodose 600 filling machine works with blended products. Complete with methods, results, diagrams, a conclusion and acknowledgements.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Applications of Capsule Dosing Techniques for Use in Dry Powder Inhalers
| By Capsugel
This article, published in 2010 in Future Science, Ltd., details the methodologies involved in dosing Dry Powder Inhalers (DPIs) such as micro-dosing and the "pepper pot" principle. It also covers Capsugel's Xcelodose™ System for DPIs.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Optimizing Antimicrobial Preservative Selection for Pharmaceutical Products
| By Spectrum Chemical
The challenges facing the formulation chemist include 1) balancing preservative selection against a broad spectrum of potential contaminants with regulations and consumer preferences generally limiting usage; 2) minimizing any adverse affect of the preservatives on the performance attributes or activity of the product 3) ensuring activity of the preservatives in the unique pharmaceutical or cosmetic formulation throughout the expected shelf life of the product. This paper will provide guidelines for selecting and optimizing an appropriate preservative system.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Binders in Tablet Manufacturing – What You Need to Know
| By Spectrum Chemical
In this regard, selecting an appropriate binder becomes difficult because dissolution and binding properties oppose each other and a balance must be found. Furthermore, the effectiveness of the binder is not intrinsic, but is influenced by many other variables in the formulation components and process. This paper provides an overview of the popular choices available, as well as some considerations for optimal binder selection
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Fermion’s New Small Scale Production Lab for High Potency API’s.
| By Fermion
Fermion has been manufacturing the important anticancer drugs Cyclophosphamide, Mercaptopurine and Methotrexate for over 40 years. Download this free white paper to find out more.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Fermion Opens New High Potency Facility Capable of Handling OEL Class V Compounds
| By Fermion
Fermion was first inspected by the US FDA in 1979. Since that time Fermion has maintained a strong regulatory track-record and has enjoyed uninterrupted commercial cGMP production across its product range. Download this free white paper to find out more.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Fermion Opens New Storage Facility for Large Volume APIs
| By Fermion
In the summer of 2011, Fermion began construction on a new finished product storage area for APIs produced at its plant in Hanko, Finland. Download this free white paper to find out more.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Fermion's Hanko Plant Maintains 'Acceptable' Status by FDA
| By Fermion
Fermion has successfully passed another FDA-inspection. Download this free white paper to find out more.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Two novel polysaccharide-based chiral stationary phases
| By Chiral Technologies
Polysaccharide-based chiral stationary phases (CSP) are successfully employed to achieve the majority of analytical and preparative enantioselective separations. However, there are a number of separations where significant modification or enhancement of selectivity is necessary. Two new columns, CHIRALPAK AY-H and CHIRALCEL OZ-H, have been introduced to meet these needs. Please download this White paper to find out more.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Creating Value in the Development Process
| By APL
APL contributes to products that improve human lives. We provide expertise and services in product development of pharmaceutical drugs, supporting clients throughout the development process – from preclinical development to commercial production of finished product.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
31-45 of 51 results